We are live on ! Find out more
3C

361 Capital Portfolio holdings

AUM $213M
1-Year Est. Return 24.26%
This Fund
S&P 500
This Quarter Est. Return
-14.01%
1 Year Est. Return
+24.26%
3 Year Est. Return
+117.64%
5 Year Est. Return
10 Year Est. Return
AUM
$489M
AUM Growth
+$28.7M
Cap. Flow
+$92.3M
Cap. Flow %
18.87%
Top 10 Hldgs %
6.48%
Holding
460
New
144
Increased
91
Reduced
67
Closed
156

Top Sells

Rank Stock Value
1
JKHY icon
Jack Henry & Associates
JKHY
+$2.89M
2
GWW icon
W.W. Grainger
GWW
+$2.62M
3
CNP icon
CenterPoint Energy
CNP
+$2.44M
4
COST icon
Costco
COST
+$2.36M
5
HUN icon
Huntsman Corp
HUN
+$2.29M

Sector Composition

Rank Sector Weight
1 Financials 15.48%
2 Technology 14.57%
3 Healthcare 12.96%
4 Industrials 12.9%
5 Consumer Discretionary 11.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XNCR icon
26
Xencor
XNCR
$1.47B
$2.6M 0.53%
+71,802
New +$2.63M
USPH icon
27
US Physical Therapy
USPH
$1.16B
$2.6M 0.53%
25,351
+10,589
+72% +$1.18M
ANF icon
28
Abercrombie & Fitch
ANF
$4.41B
$2.59M 0.53%
+129,228
New +$2.42M
ASMB icon
29
Assembly Biosciences
ASMB
$517M
$2.59M 0.53%
+9,547
New +$2.76M
JPST icon
30
JPMorgan Ultra-Short Income ETF
JPST
$40.1B
$2.59M 0.53%
+51,642
New +$2.59M
SPSC icon
31
SPS Commerce
SPSC
$2.41B
$2.58M 0.53%
62,504
+26,180
+72% +$1.14M
ABG icon
32
Asbury Automotive
ABG
$4.22B
$2.57M 0.53%
38,617
+15,209
+65% +$1M
MGRC icon
33
McGrath RentCorp
MGRC
$2.93B
$2.56M 0.52%
+49,831
New +$2.56M
MINT icon
34
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$16.9B
$2.56M 0.52%
25,317
+13,531
+115% +$1.37M
RDN icon
35
Radian Group
RDN
$5.22B
$2.55M 0.52%
155,804
+65,944
+73% +$1.2M
TIER
36
DELISTED
TIER REIT, Inc.
TIER
$2.55M 0.52%
123,418
+51,554
+72% +$1.15M
COLB icon
37
Columbia Banking Systems
COLB
$8.77B
$2.52M 0.52%
+69,577
New +$2.6M
HELE icon
38
Helen of Troy
HELE
$659M
$2.51M 0.51%
+19,149
New +$2.51M
MCS icon
39
Marcus Corp
MCS
$749M
$2.51M 0.51%
+63,497
New +$2.62M
CATM
40
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
$2.5M 0.51%
96,271
+40,369
+72% +$1.22M
QLYS icon
41
Qualys
QLYS
$4.81B
$2.5M 0.51%
33,473
+13,685
+69% +$1.03M
MEDP icon
42
Medpace
MEDP
$16.6B
$2.48M 0.51%
46,837
+19,484
+71% +$1.07M
SSP icon
43
E.W. Scripps
SSP
$278M
$2.48M 0.51%
+157,386
New +$2.63M
FOXF icon
44
Fox Factory Holding Corp
FOXF
$782M
$2.47M 0.51%
42,004
+10,005
+31% +$623K
SANM icon
45
Sanmina
SANM
$11B
$2.47M 0.51%
102,790
+52,360
+104% +$1.32M
RHP icon
46
Ryman Hospitality Properties
RHP
$8.47B
$2.47M 0.5%
37,026
+15,485
+72% +$1.16M
EGBN icon
47
Eagle Bancorp
EGBN
$860M
$2.47M 0.5%
+50,661
New +$2.58M
MTG icon
48
MGIC Investment
MTG
$6.37B
$2.47M 0.5%
235,925
+100,215
+74% +$1.17M
ARWR icon
49
Arrowhead Research
ARWR
$12.2B
$2.47M 0.5%
+198,545
New +$2.71M
PCRX icon
50
Pacira BioSciences
PCRX
$1.06B
$2.45M 0.5%
56,873
+9,703
+21% +$453K

Similar funds

361 Capital's Q4 2018 Portfolio in Review

As of Q4 2018, 361 Capital held 460 positions worth $489M, up 6.2% from $461M the previous quarter. Its ten largest holdings account for 6.5% of the portfolio.

361 Capital deployed $92.3M of net new capital in Q4 2018, opening 144 new positions and adding to 91 existing holdings. Its largest new stake was Black Hills Corp: 56,067 shares worth $3.52M.

By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Eli Lilly, an estimated $2.04M trimmed.

  • 361 Capital's largest Q4 2018 buy was Black Hills Corp: 56,067 shares worth $3.52M.
  • 361 Capital added most to CSG Systems International in Q4 2018, an estimated $2.24M increase.
  • 361 Capital's biggest Q4 2018 reduction was Eli Lilly, cutting an estimated $2.04M.
  • 361 Capital fully exited Jack Henry & Associates in Q4 2018, selling an estimated $2.89M.
  • 361 Capital's ten largest holdings make up 6.5% of its $489M portfolio in Q4 2018.
  • 361 Capital opened 144 new positions and closed 156 in Q4 2018.
  • 361 Capital's portfolio value rose 6.2% quarter-over-quarter to $489M.

Based on 361 Capital's 13F filing for Q4 2018, filed 8 Feb 2019.